The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished.  In a […] Continue reading ->
Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading ->
Artificial intelligence promises huge efficiency gains for strained health systems, but algorithmic surveillance in long-term care systems also introduces profound ethical dilemmas. In response, the World Health Organization (WHO) has unveiled a comprehensive consultation draft on global long-term care standards to ensure digital innovation is balanced with fundamental human rights. Across the world, countries are […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->
Snake bites are neglected even amongst neglected tropical diseases (NTDs), said Bangladesh’s Professor Mohammad Abul Faiz, who was awarded the prestigious Dr Lee Jong-wook Memorial Prize at an event on the sidelines of last week’s World Health Assembly (WHA). The prize is for individuals, institutions, and governmental or nongovernmental organisations whose contributions to public health […] Continue reading ->
WHO emergency funds are running low, and global health leaders are concerned about a systemic paralysis in pandemic preparedness. In high-level discussions in Geneva, experts explored the geopolitical rifts, pitting the Global South’s demand to treat pandemic tools as legally binding “public goods” against a European push for market-driven surge financing. As a severe Ebola […] Continue reading ->
WHO Member States approved a new 10-year global action plan to combat antimicrobial resistance (AMR) on Friday after a months-long fight over how the world should share AMR-related medical technologies. The plan, which runs through 2036, maps out strategies for countries to implementing the ambitious targets set at a UN High Level Meeting, including reducing […] Continue reading ->
Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading ->
This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading ->